Golden Biotechnology Corporation logo

Golden Biotechnology Corporation (4132)

Market Closed
9 Apr, 06:59
TWSE TWSE
NT$
3. 47
0
0%
NT$
2.22B Market Cap
- P/E Ratio
- Div Yield
7.06M Volume
- Eps
NT$ 3.47
Previous Close
Add Transaction
Day Range
3.47 5.09
Year Range
3.47 36.3
Want to track 4132 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4132 closed Thursday higher at NT$3.47, an increase of 0% from Wednesday's close, completing a monthly decrease of -14.321% or -NT$0.58. Over the past 12 months, 4132 stock lost -83.9352%.
4132 is not paying dividends to its shareholders.
Golden Biotechnology Corporation has completed 4 stock splits, with the recent split occurring on Nov 29, 2021.
The company's stock is traded on one exchange.

4132 Chart

People also search for

Nak Sealing Technologies Corp.
NT$ 117.5
-0.8439%
Federal Corporation
NT$ 18.8
+0.8043%
YC Co., Ltd.
NT$ 14.3
-0.6944%
Sampo Corporation
NT$ 23.25
+0.2155%
Power Wind Health Industry Co. Ltd.
NT$ 169.5
-1.1662%

Golden Biotechnology Corporation (4132) FAQ

What is the stock price today?

The current price is NT$3.47.

On which exchange is it traded?

Golden Biotechnology Corporation is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4132.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.22B.

Has Golden Biotechnology Corporation ever had a stock split?

Golden Biotechnology Corporation had 4 splits and the recent split was on Nov 29, 2021.

Golden Biotechnology Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
TWSE Exchange
TW0004132006 ISIN
Taiwan Country
- Employees
- Last Dividend
29 Nov 2021 Last Split
- IPO Date

Overview

Golden Biotechnology Corporation is a prominent entity specializing in drug discovery and the manufacturing of health food supplements. Since its inception in 2002, it has established a notable presence not only in its home country, Taiwan, but also internationally, including in the United States, Japan, China, Korea, and Singapore. The company’s efforts are geared towards the development of innovative health solutions, with a significant focus on addressing various health issues such as cancer, liver health, fatigue, autoimmune diseases, and general wellness. Positioned at the forefront of biotechnology, Golden Biotechnology Corporation leverages cutting-edge research to contribute to the betterment of health outcomes globally. Its headquarters are located in New Taipei City, Taiwan.

Products and Services

  • Liverty

    Designed to support liver health and alleviate fatigue, Liverty is a testament to Golden Biotechnology Corporation's commitment to developing products that support vital organ functions and enhance overall vitality.

  • Rasle

    This product serves as an auto-immune adjuvant therapy, offering a complementary approach to traditional autoimmune disease treatments. Rasle exemplifies the company’s dedication to innovative health solutions.

  • ZSAINO

    A nourishment product aimed at assisting individuals in recovery from illness and promoting general health improvement. ZSAINO represents the company's focus on enhancing quality of life through nutritional support.

  • UMOOZE

    A herbal formula targeted at optimizing male health. UMOOZE reflects Golden Biotechnology Corporation’s approach to natural and holistic health remedies.

  • Antroquinonol

    As a pioneering anticancer molecule, Antroquinonol is under development for treating a range of conditions including pancreatic cancer, acute myeloid leukemia, hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. This flagship product underscores the company’s commitment to groundbreaking research in cancer treatment and cardiovascular health.

Contact Information

Address: No. 27-6, Zhongzheng E. Road
Phone: 886 2 2808 6006